Education Center
Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc: Prior Public Sale may destroy novelty without disclosure of inventive feature
In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc, the United States Supreme Court held that a prior public sale of a patented product could destroy the novelty of a patent for that product even though there was no disclosure of the...
Read ArticleSCOTUS GRANTS THE LOSS OF OVERSEAS PROFITS TO BE INCLUDED IN DAMAGES IN WESTERN GECO LLC V. ION GEOPHYSICAL CORPORATION
On June 22, 2018 in WesternGeco LLC v. Ion Geophysical Corporation, the Supreme Court held in a 7 – 2 decision written by Thomas J with Gorsuch and Breyer JJ dissenting that the loss of foreign profits resulting from the infringing export from the...
Read Article
IT’S 2018: THE IMPACT OF IP DECISIONS FROM 2017
2017 saw a bumper crop of Supreme Court decisions on intellectual property matters around the world including eight by the United States Supreme Court, two by the Canadian Supreme Court, and two by the United Kingdom Supreme Court. U.S. Supreme...
Read ArticleCLEVELAND INDIANS TO DISCONTINUE USE OF CHIEF WAHOO ON PLAYER UNIFORMS; LIMITED USE OF THE LOGO TO CONTINUE IN ORDER TO PRESERVE FEDERAL TRADEMARK RIGHTS
<a href=”https://ladas.com/wp-content/uploads/2016/10/bigstock-Mahogany-wooden-gavel-on-gloss-9_30_16-123240980-72-dpi-sm.jpg”><img class=” wp-image-5006 alignleft”...
Read ArticleWASHINGTON REDSKINS’ US TRADEMARK REGISTRATIONS REINSTATED BY THE FOURTH CIRCUIT
On January 18, 2018, the U.S. Court of Appeals for the Fourth Circuit reinstated the Washington Redskins’ federal trademark registrations originally cancelled by the Trademark Trials and Appeals Board (“TTAB”) in 2014 in light of the Supreme...
Read ArticleSKIPPING THE PATENT DANCE: U.S. SUPREME COURT IN AMGEN v SANDOZ MAKES IT MORE DIFFICULT FOR PATENT OWNERS TO DELAY MARKETING OF BIOSIMILARS
On June 12, 2017, in a unanimous decision authored by Justice Thomas in Amgen Inc. v. Sandoz Inc., the United States Supreme Court considered the complex statutory scheme that attempts to expedite resolution of patent disputes that might affect the...
Read Article